Stiff person syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 31: Line 31:
==Causes==
==Causes==
Because many patients with SPS have circulating antibodies to the enzyme [[L-glutamic acid decarboxylase|glutamic acid decarboxylase]] (GAD),<ref>{{cite journal | author=Murinson BB | title=Stiff-person syndrome | journal=Neurologist | year=2004 | pages=131-7 | volume=10 | issue=3  | id=PMID 15140273}}</ref> an [[autoimmune]] cause of the disease has been postulated.  However, [[L-glutamic acid decarboxylase|GAD]] antibodies cannot be the sole cause, as most [[Diabetes mellitus type 1|Type I diabetics]] possess anti-GAD antibodies, yet the frequency of SPS among Type I diabetics is 1 in 10,000.<ref>{{cite journal |author=Levy L, Dalakas M, Floeter M |title=The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid |journal=Ann Intern Med |volume=131 |issue=7 |pages=522-30 |year=1999 |pmid=10507962}}</ref>  The GAD protein regions ([[epitopes]]) recognized by these antibodies may differ in each disease.<ref name="Hampe"> </ref>
Because many patients with SPS have circulating antibodies to the enzyme [[L-glutamic acid decarboxylase|glutamic acid decarboxylase]] (GAD),<ref>{{cite journal | author=Murinson BB | title=Stiff-person syndrome | journal=Neurologist | year=2004 | pages=131-7 | volume=10 | issue=3  | id=PMID 15140273}}</ref> an [[autoimmune]] cause of the disease has been postulated.  However, [[L-glutamic acid decarboxylase|GAD]] antibodies cannot be the sole cause, as most [[Diabetes mellitus type 1|Type I diabetics]] possess anti-GAD antibodies, yet the frequency of SPS among Type I diabetics is 1 in 10,000.<ref>{{cite journal |author=Levy L, Dalakas M, Floeter M |title=The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid |journal=Ann Intern Med |volume=131 |issue=7 |pages=522-30 |year=1999 |pmid=10507962}}</ref>  The GAD protein regions ([[epitopes]]) recognized by these antibodies may differ in each disease.<ref name="Hampe"> </ref>
==Differeniating Stiff Person Syndrome from other Diseases==
One the basis of stiffness and fever it can be differentiated from:
*[[Tetanus]]
*[[Neuroleptic malignant syndrome]]
*[[Meningitis]]
*[[Tardive dyskinesia]]
*[[Parkinsonism]]
{| style="border: 2px solid #DCDCDC; font-size: 90%; width: 83%;"
|+ '''Differential Diagnosis of Tetanus'''
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Disease
! colspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Diagnosis
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Treatment
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" |Signs
! align="center" style="background:#4479BA; color: #FFFFFF;" |Laboratory Findings
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Tetanus]]<ref name="pmid27538652">{{cite journal| author=Woldeamanuel YW, Andemeskel AT, Kyei K, Woldeamanuel MW, Woldeamanuel W| title=Case fatality of adult tetanus in Africa: Systematic review and meta-analysis. | journal=J Neurol Sci | year= 2016 | volume= 368 | issue=  | pages= 292-9 | pmid=27538652 | doi=10.1016/j.jns.2016.07.025 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27538652  }} </ref><ref name="pmid26598719">{{cite journal| author=Thwaites CL, Loan HT| title=Eradication of tetanus. | journal=Br Med Bull | year= 2015 | volume= 116 | issue=  | pages= 69-77 | pmid=26598719 | doi=10.1093/bmb/ldv044 | pmc=4674006 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26598719  }} </ref>
| style="background: #DCDCDC; padding: 5px;" |
*Tonic contraction of muscles between the spasmodic episodes
*[[Trismus]] or lockjaw
* [[Neck stiffness]]
* [[Swallowing difficulty]]
* Stiffening of the calf and pectoral muscle groups
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
* [[Opisthotonos]]
* Leg [[extension]] with arm [[flexion]]
* [[Risus sardonicus]]
* [[respiratory distress]]
| style="background: #DCDCDC; padding: 5px;" |
* Not significant
| style="background: #DCDCDC; padding: 5px;" |
* [[Diazepam]]
* [[Magnesium]] 
* Human TIG
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Neuroleptic malignant syndrome|Neuroleptic Malignant Syndrome]] <ref name="pmid28533580">{{cite journal| author=Hosseini S, Elyasi F| title=Olanzapine-Induced Neuroleptic Malignant Syndrome. | journal=Iran J Med Sci | year= 2017 | volume= 42 | issue= 3 | pages= 306-309 | pmid=28533580 | doi= | pmc=5429500 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28533580  }} </ref><ref name="pmid28488314">{{cite journal| author=Leenhardt F, Perier D, Pinzani V, Giraud I, Villiet M, Castet-Nicolas A et al.| title=Pharmacist intervention to detect drug adverse events on admission to the emergency department: Two case reports of neuroleptic malignant syndrome. | journal=J Clin Pharm Ther | year= 2017 | volume=  | issue=  | pages=  | pmid=28488314 | doi=10.1111/jcpt.12531 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28488314  }} </ref>
| style="background: #DCDCDC; padding: 5px;" |
*History of intake of offending drugs e.g [[neuroleptics]] like:
**[[Fluphenazine]]
**[[Haloperidol]]
**[[Olanzapine]]
**[[Risperidone]]
*[[Autonomic instability]]
*[[Stiffness|Rigidity]]
*[[Disorientation]]
*[[Fever]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
* [[Dysphagia]]
* [[Pallor]]
* [[Dyspnea]]
* [[Shuffling gait]]
* [[Agitation]]
| style="background: #DCDCDC; padding: 5px;" |
** [[Myoglobinemia]]
** Elevated [[LDH]]
** Elevated [[creatine kinase]]
** [[Hyperkalemia]]
** Elevated [[AST]] and [[ALT]]
** [[Hyperphosphatemia]]
** Elevated [[alkaline phosphatase]]
** [[Hyperuricemia]]
| style="background: #DCDCDC; padding: 5px;" |
* Supportive therapy
* Stop the offending agent
* Medical Therapy
** [[Dantrolene]]
** [[Amantadine]]
** [[Bromocriptine]]
|-
| style="background: #F5F5F5; padding: 5px;" | [[Meningitis|Viral Meningitis]]<ref name="pmid24326618">{{cite journal| author=Chow E, Troy SB| title=The differential diagnosis of hypoglycorrhachia in adult patients. | journal=Am J Med Sci | year= 2014 | volume= 348 | issue= 3 | pages= 186-90 | pmid=24326618 | doi=10.1097/MAJ.0000000000000217 | pmc=4065645 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24326618  }} </ref><ref name="pmid22880096">{{cite journal| author=Leen WG, Willemsen MA, Wevers RA, Verbeek MM| title=Cerebrospinal fluid glucose and lactate: age-specific reference values and implications for clinical practice. | journal=PLoS One | year= 2012 | volume= 7 | issue= 8 | pages= e42745 | pmid=22880096 | doi=10.1371/journal.pone.0042745 | pmc=3412827 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22880096  }} </ref><ref name="pmid15319091">{{cite journal| author=Tyler KL| title=Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's. | journal=Herpes | year= 2004 | volume= 11 Suppl 2 | issue=  | pages= 57A-64A | pmid=15319091 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15319091  }} </ref>
| style="background: #DCDCDC; padding: 5px;" |
* [[Fever]]
* [[Irritability]]
* Lack of appetite
* [[Lethargy]]
* Disoriented
* High grade [[fever]]
* Severe [[headache]]
* [[Stiff neck]]
* [[Photophobia|Sensitivity to bright light]]
* [[Nausea]]
* [[Vomiting]]
| style="background: #F5F5F5; padding: 5px;" |
*[[Headache]]
*[[Photophobia]]
*Phonophopia
*[[Pharyngitis]] in case of [[enterovirus]] infeciton
*[[Orchitis]] (In mumps)
*[[Vesicular]] or [[macular]] [[skin rash]]
*[[Petechia|Petichiae]]
*[[Nuchal rigidity]]
*Signs of [[meningeal irritation]]:
**[[Kernig's sign]]
**[[Brudzinski's sign]]
*[[Altered mental status]]
*[[Hypotonia]]
| style="background: #DCDCDC; padding: 5px;" |
*[[CSF]] / [[plasma glucose]] ratio (>0.6)
*[[Lactate]] (mmols/l) (<2.1)
*[[Lymphocytes]] > [[granulocytes]]
| style="background: #DCDCDC; padding: 5px;" |
* Supportive
** [[Analgesics]] for [[pain]].
** [[Acetaminophen]] for [[fever]].
* Anti-viral therapy:
** [[Acyclovir]]
** [[Pleconaril]]
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Stiff man syndrome]]
| style="background: #DCDCDC; padding: 5px;" |
* Marked rigidity
* [[Spasms]]
** Intermittent
** Painful
** Absent during sleep
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
* [[Diaphoresis]]
* [[Arterial hypertension]]
* [[Tachypnea]]
* [[Cyanosis]]
* [[Apnea]], [[tachypnea]]
* [[Respiratory arrest]]
* Dilatation of the pupils
* [[Tachycardia]]
| style="background: #DCDCDC; padding: 5px;" |
* [[CSF]] has
** Elevated [[IgG]]
** [[Oligoclonal bands]]
* Positive anti-GAD antibodies
* Elevated [[creatine kinase]]
* Normal CBC & ESR
| style="background: #DCDCDC; padding: 5px;" |
* [[Benzodiazepines]]
* B[[Baclofen|aclofen]]
* [[Vigabatrin]] 
* [[Valproic Acid]], [[Neurontin]]
* Injected [[botulinum toxin]] 
* [[Prednisone]], [[plasmapheresis]], [[IVIG]] ( some success)
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Drug]] induced  [[Tardive dyskinesia|(Tardive dyskinesia]])<ref name="pmid28552340">{{cite journal| author=Deng ZD, Li DY, Zhang CC, Pan YX, Zhang J, Jin H et al.| title=Long-term follow-up of bilateral subthalamic deep brain stimulation for refractory tardive dystonia. | journal=Parkinsonism Relat Disord | year= 2017 | volume=  | issue=  | pages=  | pmid=28552340 | doi=10.1016/j.parkreldis.2017.05.010 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28552340  }} </ref><ref name="pmid28520698">{{cite journal| author=| title=Valbenazine (Ingrezza) for tardive dyskinesia. | journal=Med Lett Drugs Ther | year= 2017 | volume= 59 | issue= 1521 | pages= 83-84 | pmid=28520698 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28520698  }} </ref><ref name="pmid28510661">{{cite journal| author=Voelker R| title=Tardive Dyskinesia Drug Approved. | journal=JAMA | year= 2017 | volume= 317 | issue= 19 | pages= 1942 | pmid=28510661 | doi=10.1001/jama.2017.5537 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28510661  }} </ref>
| style="background: #DCDCDC; padding: 5px;" |
*History of intake of the offending drug for at least one month
**[[Neuroleptics]] ([[antipsychotics]])
**[[Metoclopramide]]
*Eye deviation
*Head and neck jerky movements
*No tonic contraction of the muscles between the spasms
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
* [[Dyskinesia]] of the tongue and lips
* [[Dyskinesia]] of the limbs
* [[Dyskinesia]] of the neck
| style="background: #DCDCDC; padding: 5px;" |
* It is a clinical diagnosis depending on
** [[Dyskinetic|Dyskinetic movements]]
** Hx of > 1 month of [[Antipsychotics|antipsychotic]] use
* Labs may be done to rule out other differentials
| style="background: #DCDCDC; padding: 5px;" |
* Stop the offending agent
* [[Benztropine]]
* [[Benzodiazepines]]
* Injection of [[botulinum toxin]]
* Valbenzine
* [[Tetrabenazine]]
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Strychnine poisoning]]<ref>{{Cite journal
| author = [[Charlotte Duverneuil]], [[Geoffroy Lorin de la Grandmaison]], [[Philippe de Mazancourt]] & [[Jean-Claude Alvarez]]
| title = Liquid chromatography/photodiode array detection for determination of strychnine in blood: a fatal case report
| journal = [[Forensic science international]]
| volume = 141
| issue = 1
| pages = 17–21
| year = 2004
| month = April
| doi = 10.1016/j.forsciint.2003.12.010
| pmid = 15066709
}}</ref><ref>{{Cite journal
| author = [[B. A. Smith]]
| title = Strychnine poisoning
| journal = [[The Journal of emergency medicine]]
| volume = 8
| issue = 3
| pages = 321–325
| year = 1990
| month = May-June
| pmid = 2197324
}}</ref><ref>{{Cite journal
| author = [[B. J. Maron]], [[J. R. Krupp]] & [[B. Tune]]
| title = Strychnine poisoning successfully treated with diazepam
| journal = [[The Journal of pediatrics]]
| volume = 78
| issue = 4
| pages = 697–699
| year = 1971
| month = April
| pmid = 5547830
}}</ref><ref>{{Cite journal
| author = [[B. Oberpaur]], [[A. Donoso]], [[C. Claveria]], [[C. Valverde]] & [[M. Azocar]]
| title = Strychnine poisoning: an uncommon intoxication in children
| journal = [[Pediatric emergency care]]
| volume = 15
| issue = 4
| pages = 264–265
| year = 1999
| month = August
| pmid = 10460082
}}</ref>
   
| style="background: #DCDCDC; padding: 5px;" |
*Hx of up to date tetanus immunizations
*History of intentional or accidental intake
**''Strychnos nux vomica seeds''
**Rodenticide
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
* Hypervigilance
* Anxiety
* Mydriasis
* Hypereflexia
* Clonus
* Facial and neck stiffness
| style="background: #DCDCDC; padding: 5px;" |
* Blood assay
* Tissue assay
* Urine assay
| style="background: #DCDCDC; padding: 5px;" |
* Initial stabilization
* High dose [[Benzodiazepines]]
* Intubation and airway securing
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Hypocalcaemia]]<ref name="pmid27065735">{{cite journal| author=Chhabra P, Rana SS, Sharma V, Sharma R, Bhasin DK| title=Hypocalcemic tetany: a simple bedside marker of poor outcome in acute pancreatitis. | journal=Ann Gastroenterol | year= 2016 | volume= 29 | issue= 2 | pages= 214-20 | pmid=27065735 | doi=10.20524/aog.2016.0015 | pmc=4805743 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27065735  }} </ref><ref name="pmid24171002">{{cite journal| author=Desai M, Kolla PK, Reddy PL| title=Calcium unresponsive hypocalcemic tetany: gitelman syndrome with hypocalcemia. | journal=Case Rep Med | year= 2013 | volume= 2013 | issue=  | pages= 197374 | pmid=24171002 | doi=10.1155/2013/197374 | pmc=3792521 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24171002  }} </ref>
| style="background: #DCDCDC; padding: 5px;" |
**[[Muscle]] [[twitching]] and [[cramping]]
**Circumoral and extremity [[paresthesia]] or [[tingling]]
** [[Altered mental status]]
** [[Irritability]]
** [[Depression]]
** [[Psychosis]]
** [[Seizure]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
** [[Tetany (medical sign)|Tetany]] (carpopedal spasm)
** Latent tetany
*** [[Trousseau sign of latent tetany]] 
*** [[Chvostek's sign]] 
** Hyperactive tendon reflexes
| style="background: #DCDCDC; padding: 5px;" |
* Decreased blood [[calcium]] levels
| style="background: #DCDCDC; padding: 5px;" |
* Two [[Ampule|ampules]] of [[intravenous]] [[calcium gluconate]] 10% is given slowly in a period of 10 minutes, or
* If hypocalcemia is severe, [[calcium chloride]] is given instead
* Maintenance doses of both calcium and [[vitamin-D]]
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Dental abscess]]<ref name="pmid28317564">{{cite journal| author=Ogle OE| title=Odontogenic Infections. | journal=Dent Clin North Am | year= 2017 | volume= 61 | issue= 2 | pages= 235-252 | pmid=28317564 | doi=10.1016/j.cden.2016.11.004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28317564  }} </ref><ref name="pmid27930461">{{cite journal| author=Bertossi D, Barone A, Iurlaro A, Marconcini S, De Santis D, Finotti M et al.| title=Odontogenic Orofacial Infections. | journal=J Craniofac Surg | year= 2017 | volume= 28 | issue= 1 | pages= 197-202 | pmid=27930461 | doi=10.1097/SCS.0000000000003250 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27930461  }} </ref>
| style="background: #DCDCDC; padding: 5px;" |
* Tooth pain
* Painful eating and chewing
* [[Fever]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
* Poor oral hygiene
* Presence of a dental infection
* Swollen gums
* No progression of spasm with time
* Cheek swelling
| style="background: #DCDCDC; padding: 5px;" |
* Clinical diagnosis
* Labs may include
** Microscopic exam of stained smear
** Culture of oral swab
** Blood culture
| style="background: #DCDCDC; padding: 5px;" |
* Improved dental hygiene
** Use of fluoridated water
** Brushing regularly
* [[Antibiotics]]
* Dental extraction in case of severity
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Parkinson's disease]]<ref name="pmid11402154">{{cite journal| author=Olanow CW, Watts RL, Koller WC| title=An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. | journal=Neurology | year= 2001 | volume= 56 | issue= 11 Suppl 5 | pages= S1-S88 | pmid=11402154 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11402154  }} </ref><ref name="pmid24756517">{{cite journal| author=Connolly BS, Lang AE| title=Pharmacological treatment of Parkinson disease: a review. | journal=JAMA | year= 2014 | volume= 311 | issue= 16 | pages= 1670-83 | pmid=24756517 | doi=10.1001/jama.2014.3654 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24756517  }} </ref>
| style="background: #DCDCDC; padding: 5px;" |
* [[Stiffness]]
* Inability to write
* Jerky movements at rest
* [[Constipation]]
* Sleeping difficulty
* Walking difficulty
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
* [[Tremor]]
* Rigidity
* [[Bradykinesia]]
* [[Postural instability]]
* Shuffling gait
| style="background: #DCDCDC; padding: 5px;" |
* Clinical diagnosis
* Improvement with dopaminergic therapy confirms diagnosis
| style="background: #DCDCDC; padding: 5px;" |
* Symptomatic therapy
* [[Dopamine agonists]]
* [[Levodopa]]
* [[Amantadine]]
* [[MAO inhibitors]]
* COMT inhibitors
* [[Anticholinergics]]
|}


==Natural History, Complications and Prognosis==
==Natural History, Complications and Prognosis==

Revision as of 20:42, 12 June 2017

Stiff person syndrome
ICD-10 G25.8
ICD-9 333.91
OMIM 184850
DiseasesDB 12428
MeSH D016750

Template:Search infobox

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Stiff person syndrome (SPS) (or occasionally, stiff-man syndrome) is a rare neurologic disorder of unknown etiology.

Historical Perspective

SPS was first described by Moersch and Woltman at the Mayo Clinic in 1956.[1]

Classification

There are 3 categories of SPS, and they are as follows:

  1. SPS
  2. Progressive encephalomyelitis with rigidity (rapidly progressive disorder, fatal within 16 weeks)
  3. Stiff-limb syndrome (asymmetric rigidity and spasms in the distal extremities or face)

Causes

Because many patients with SPS have circulating antibodies to the enzyme glutamic acid decarboxylase (GAD),[2] an autoimmune cause of the disease has been postulated. However, GAD antibodies cannot be the sole cause, as most Type I diabetics possess anti-GAD antibodies, yet the frequency of SPS among Type I diabetics is 1 in 10,000.[3] The GAD protein regions (epitopes) recognized by these antibodies may differ in each disease.[4]

Differeniating Stiff Person Syndrome from other Diseases

One the basis of stiffness and fever it can be differentiated from:


Differential Diagnosis of Tetanus
Disease Diagnosis Treatment
Symptoms Signs Laboratory Findings
Tetanus[5][6]
  • Not significant
Neuroleptic Malignant Syndrome [7][8]
Viral Meningitis[9][10][11]
Stiff man syndrome
  • Marked rigidity
  • Spasms
    • Intermittent
    • Painful
    • Absent during sleep
Drug induced (Tardive dyskinesia)[12][13][14]
  • History of intake of the offending drug for at least one month
  • Eye deviation
  • Head and neck jerky movements
  • No tonic contraction of the muscles between the spasms
Strychnine poisoning[15][16][17][18]
  • Hx of up to date tetanus immunizations
  • History of intentional or accidental intake
    • Strychnos nux vomica seeds
    • Rodenticide
  • Hypervigilance
  • Anxiety
  • Mydriasis
  • Hypereflexia
  • Clonus
  • Facial and neck stiffness
  • Blood assay
  • Tissue assay
  • Urine assay
  • Initial stabilization
  • High dose Benzodiazepines
  • Intubation and airway securing
Hypocalcaemia[19][20]
Dental abscess[21][22]
  • Tooth pain
  • Painful eating and chewing
  • Fever
  • Poor oral hygiene
  • Presence of a dental infection
  • Swollen gums
  • No progression of spasm with time
  • Cheek swelling
  • Clinical diagnosis
  • Labs may include
    • Microscopic exam of stained smear
    • Culture of oral swab
    • Blood culture
  • Improved dental hygiene
    • Use of fluoridated water
    • Brushing regularly
  • Antibiotics
  • Dental extraction in case of severity
Parkinson's disease[23][24]
  • Clinical diagnosis
  • Improvement with dopaminergic therapy confirms diagnosis

Natural History, Complications and Prognosis

Prognosis is variable and there is no reliable predictor of speed and severity of disease onset. Muscle tetany may lead to muscle rupture and broken bones, or problems swallowing and breathing in severe cases.[25]

Diagnosis

History

  • 10% of patients have generalized seizures or myoclonus.
  • Fixed thoracolumbar lordosis of the spine develops in nearly all cases from co-contraction of abd/paraspinal muscles.

Symptoms

Those with the illness experience progressive, fluctuating tonic muscle contractions, particularly the axial musculature. Depression and anxiety are often noted although this may be a result of discomfort due to stiffness, rather than underlying neurochemical abnormalities. MRI detection of GABA in the brain have demonstrated reduced levels in stiff-person syndrome.[4] Some of the symptoms are listed below.

  • Marked rigidity and painful spasms, particularly in the thoracic and lumbosacral paraspinal, abdominal, and proximal lower extremity muscles
  • Onset usually insidious
  • Persistent contraction leads to a “board-like” quality.
  • Intermittent painful spasms which may lead to falls due to instability.
  • Spasms are NOT present during sleep.

Laboratory Findings

  • Paraneoplastic cases often are GAD negative, and they have anti-Amphyphysin.
  • The CSF is abnormal with increased IgG and oligoclonal bands.
  • 65% have anti-GAD antibodies.
  • Serum CK levels are often elevated due to a constant state of contraction of muscles.

Treatment

Treatment is mostly palliative with muscle relaxants which enhance GABA production such as benzodiazepines, which lose their effectiveness as the illness progresses.

In the absence of double-blind, placebo-controlled class A trials to determine treatment efficacy, some authorities recommend humane trials of immunosuppressive therapy, plasmapheresis or intravenous immunoglobulin infusion.

Pharmacotherapy

Acute Pharmacotherapies

References

  1. Moersch FP, Woltman HW (1956). "Progressive fluctuating muscular rigidity and spasm ("stiff-man" syndrome); report of a case and some observations in 13 other cases". Mayo Clin Proc. 31 (15): 421–7. PMID 13350379.
  2. Murinson BB (2004). "Stiff-person syndrome". Neurologist. 10 (3): 131–7. PMID 15140273.
  3. Levy L, Dalakas M, Floeter M (1999). "The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid". Ann Intern Med. 131 (7): 522–30. PMID 10507962.
  4. 4.0 4.1 Hampe C, Hammerle L, Bekris L, Ortqvist E, Kockum I, Rolandsson O, Landin-Olsson M, Törn C, Persson B, Lernmark A (2000). "Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes". J Clin Endocrinol Metab. 85 (12): 4671–9. PMID 11134126.
  5. Woldeamanuel YW, Andemeskel AT, Kyei K, Woldeamanuel MW, Woldeamanuel W (2016). "Case fatality of adult tetanus in Africa: Systematic review and meta-analysis". J Neurol Sci. 368: 292–9. doi:10.1016/j.jns.2016.07.025. PMID 27538652.
  6. Thwaites CL, Loan HT (2015). "Eradication of tetanus". Br Med Bull. 116: 69–77. doi:10.1093/bmb/ldv044. PMC 4674006. PMID 26598719.
  7. Hosseini S, Elyasi F (2017). "Olanzapine-Induced Neuroleptic Malignant Syndrome". Iran J Med Sci. 42 (3): 306–309. PMC 5429500. PMID 28533580.
  8. Leenhardt F, Perier D, Pinzani V, Giraud I, Villiet M, Castet-Nicolas A; et al. (2017). "Pharmacist intervention to detect drug adverse events on admission to the emergency department: Two case reports of neuroleptic malignant syndrome". J Clin Pharm Ther. doi:10.1111/jcpt.12531. PMID 28488314.
  9. Chow E, Troy SB (2014). "The differential diagnosis of hypoglycorrhachia in adult patients". Am J Med Sci. 348 (3): 186–90. doi:10.1097/MAJ.0000000000000217. PMC 4065645. PMID 24326618.
  10. Leen WG, Willemsen MA, Wevers RA, Verbeek MM (2012). "Cerebrospinal fluid glucose and lactate: age-specific reference values and implications for clinical practice". PLoS One. 7 (8): e42745. doi:10.1371/journal.pone.0042745. PMC 3412827. PMID 22880096.
  11. Tyler KL (2004). "Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's". Herpes. 11 Suppl 2: 57A–64A. PMID 15319091.
  12. Deng ZD, Li DY, Zhang CC, Pan YX, Zhang J, Jin H; et al. (2017). "Long-term follow-up of bilateral subthalamic deep brain stimulation for refractory tardive dystonia". Parkinsonism Relat Disord. doi:10.1016/j.parkreldis.2017.05.010. PMID 28552340.
  13. "Valbenazine (Ingrezza) for tardive dyskinesia". Med Lett Drugs Ther. 59 (1521): 83–84. 2017. PMID 28520698.
  14. Voelker R (2017). "Tardive Dyskinesia Drug Approved". JAMA. 317 (19): 1942. doi:10.1001/jama.2017.5537. PMID 28510661.
  15. Charlotte Duverneuil, Geoffroy Lorin de la Grandmaison, Philippe de Mazancourt & Jean-Claude Alvarez (2004). "Liquid chromatography/photodiode array detection for determination of strychnine in blood: a fatal case report". Forensic science international. 141 (1): 17–21. doi:10.1016/j.forsciint.2003.12.010. PMID 15066709. Unknown parameter |month= ignored (help)
  16. B. A. Smith (1990). "Strychnine poisoning". The Journal of emergency medicine. 8 (3): 321–325. PMID 2197324. Unknown parameter |month= ignored (help)
  17. B. J. Maron, J. R. Krupp & B. Tune (1971). "Strychnine poisoning successfully treated with diazepam". The Journal of pediatrics. 78 (4): 697–699. PMID 5547830. Unknown parameter |month= ignored (help)
  18. B. Oberpaur, A. Donoso, C. Claveria, C. Valverde & M. Azocar (1999). "Strychnine poisoning: an uncommon intoxication in children". Pediatric emergency care. 15 (4): 264–265. PMID 10460082. Unknown parameter |month= ignored (help)
  19. Chhabra P, Rana SS, Sharma V, Sharma R, Bhasin DK (2016). "Hypocalcemic tetany: a simple bedside marker of poor outcome in acute pancreatitis". Ann Gastroenterol. 29 (2): 214–20. doi:10.20524/aog.2016.0015. PMC 4805743. PMID 27065735.
  20. Desai M, Kolla PK, Reddy PL (2013). "Calcium unresponsive hypocalcemic tetany: gitelman syndrome with hypocalcemia". Case Rep Med. 2013: 197374. doi:10.1155/2013/197374. PMC 3792521. PMID 24171002.
  21. Ogle OE (2017). "Odontogenic Infections". Dent Clin North Am. 61 (2): 235–252. doi:10.1016/j.cden.2016.11.004. PMID 28317564.
  22. Bertossi D, Barone A, Iurlaro A, Marconcini S, De Santis D, Finotti M; et al. (2017). "Odontogenic Orofacial Infections". J Craniofac Surg. 28 (1): 197–202. doi:10.1097/SCS.0000000000003250. PMID 27930461.
  23. Olanow CW, Watts RL, Koller WC (2001). "An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines". Neurology. 56 (11 Suppl 5): S1–S88. PMID 11402154.
  24. Connolly BS, Lang AE (2014). "Pharmacological treatment of Parkinson disease: a review". JAMA. 311 (16): 1670–83. doi:10.1001/jama.2014.3654. PMID 24756517.
  25. http://www.emedicine.com/neuro/topic353.htm#target1

See also

External links

Template:Diseases of the nervous system

de:Stiff-man-Syndrom Template:WH Template:WS